anmelden
NASDAQ Composite Index
26.506,99
PKT
-77,07
PKT
-0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.03.11 | Apple overweight | JP Morgan Chase & Co. | |
| 03.03.11 | ON Semiconductor overweight | JP Morgan Chase & Co. | |
| 02.03.11 | Oracle buy | Stifel, Nicolaus & Co., Inc. | |
| 03.03.11 | Apple overweight | Barclays Capital | |
| 02.03.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 02.03.11 | Ionis Pharmaceuticals overweight | Barclays Capital | |
| 02.03.11 | Abbott Laboratories overweight | Barclays Capital | |
| 03.03.11 | Apple outperform | Morgan Keegan & Co., Inc. | |
| 03.03.11 | Paccar neutral | Credit Suisse Group | |
| 03.03.11 | Myriad Genetics sell | Goldman Sachs Group Inc. | |
| 01.03.11 | NetScout Systems outperform | Morgan Keegan & Co., Inc. | |
| 01.03.11 | Expeditors International of Washington buy | UBS AG | |
| 01.03.11 | Amazon halten | Öko Invest | |
| 02.03.11 | VeriSign outperform | Credit Suisse Group | |
| 01.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 28.02.11 | Amazon neutral | UBS AG | |
| 28.02.11 | Deckers Outdoor overweight | Barclays Capital | |
| 28.02.11 | Autodesk overweight | Barclays Capital | |
| 28.02.11 | Salesforce hold | Citigroup Corp. | |
| 28.02.11 | Salesforce overweight | Piper Jaffray & Co. | |
| 25.02.11 | Autodesk neutral | Credit Suisse Group | |
| 25.02.11 | Applied Materials buy | Stifel, Nicolaus & Co., Inc. | |
| 25.02.11 | Salesforce buy | Stifel, Nicolaus & Co., Inc. | |
| 28.02.11 | NVIDIA halten | Nasd@q Inside | |
| 25.02.11 | Applied Materials neutral | Credit Suisse Group | |
| 25.02.11 | Salesforce neutral | Credit Suisse Group | |
| 25.02.11 | Garmin equal-weight | Barclays Capital | |
| 25.02.11 | NVIDIA kaufen | Der Aktionär | |
| 25.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 25.02.11 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 24.02.11 | Vertex Pharmaceuticals hold | ThinkEquity Partners LLC | |
| 24.02.11 | Garmin neutral | Wedbush Morgan Securities Inc. | |
| 24.02.11 | Garmin sector perform | RBC Capital Markets | |
| 24.02.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 25.02.11 | Vertex Pharmaceuticals overweight | Piper Jaffray & Co. | |
| 28.02.11 | Biogen outperform | RBC Capital Markets | |
| 24.02.11 | Autodesk overweight | Barclays Capital | |
| 24.02.11 | Apple overweight | Barclays Capital | |
| 25.02.11 | Vertex Pharmaceuticals buy | Goldman Sachs Group Inc. | |
| 24.02.11 | Myriad Genetics sell | Goldman Sachs Group Inc. |
